Ian Macleod Pulls Back at Glengoyne and Rosebank as Scotch Hits a Wall
The numbers coming out of Broxburn tell a story the Scotch industry can no longer afford to whisper. Ian Macleod Distillers, one of Scotland's last major family-owned whisky businesses, has disclosed a 30% cut in annual production across two of its flagship distilleries — a stark and deliberate response to a global market that has quietly gone sideways on one of the world's most storied spirits categories. For enthusiasts who have watched Glengoyne and Rosebank command increasing reverence on the secondary market over the past decade, this is not a routine operational footnote. It is a signal from the inside of a business that has been making Scotch for generations, and it arrives with hard financial data to back it up.
The Cuts: What Happened, and Where
Ian Macleod Distillers has revealed it cut production at two distilleries by 30% due to the muted outlook for Scotch. In a filing with Companies House, the UK business register, the company said it had lowered annual production at its Glengoyne and Rosebank sites "on account of the lower forward demand outlook." The phrasing is careful, but the meaning is plain: the company does not expect near-term demand to absorb what those stills are capable of producing, so it is throttling back rather than warehousing unsellable spirit.
Production at Tamdhu Distillery "remained at reduced output levels" following "significant on-site engineering works across recent years," and the company added: "The broader trend is that Tamdhu's output profile will mirror that of the other two distilleries." In other words, all three of Ian Macleod's Scotch malt distilleries are now running at diminished capacity — a coordinated, portfolio-wide pullback rather than a targeted fix at one underperforming site.
Rosebank: A Revival Dimmed Before It Could Shine
The Rosebank reduction carries particular weight. In October 2017, Ian Macleod bought the trademark for Rosebank distillery from Diageo and the distillery site from Scottish Canals with the intention of reopening it, and in July 2023, production restarted at Rosebank Distillery. That made Rosebank one of the most anticipated distillery revivals in recent Scottish whisky history. A Lowland single malt that had been silent since 1993, Rosebank's return was met with genuine excitement from collectors and blenders alike. Cutting production there less than two years after restarting the stills is a sharp reality check — the market that greeted Rosebank's return has softened considerably faster than anyone anticipated when the investment decision was made.
Glengoyne: The Highland Stalwart Feels the Pressure
Glengoyne is the commercial engine of Ian Macleod's portfolio, a Highland single malt known for its unpeated style and unhurried distillation at one of Scotland's slowest-run stills. The company achieved a long-held ambition of becoming a distiller when it purchased Glengoyne from The Edrington Group for £7.2 million in 2003. In the two decades since, it has grown from a well-kept regional secret into a genuinely international brand, particularly strong in travel retail and Asian markets. The fact that Glengoyne, with all its brand equity, is absorbing a 30% production cut alongside a brand-new distillery like Rosebank underscores just how broad the demand problem really is.
The Financial Damage: A Full Picture
The production cuts did not happen in isolation — they emerged alongside a set of annual accounts that make for difficult reading. Turnover at the Scotch whisky business fell by 8% to £118.0m in the year ended 30 September 2025, while profits before tax slumped 45.8% to £8.6m, newly filed accounts at Companies House showed. Operating profit dropped from £22.3m to £16.8m, while profit attributable to members of the company more than halved from £11.6m to £5.5m.
Those are material declines across every relevant metric. Context matters here: this is a family-owned private company, not a listed conglomerate that can absorb losses across a diversified global portfolio. When profit attributable to members more than halves in a single fiscal year, the people running the business feel it directly. For the Russell family, who have led Ian Macleod across multiple generations, this kind of year demands decisive action — and cutting production is exactly that.
Bulk Whisky: The Hidden Engine Seizes Up
The loudest alarm in the filing is not about cased goods at all. Ian Macleod Distillers said "cased turnover grew modestly" but turnover from bulk whisky "continued to reduce at a significant, double-digit rate." Bulk whisky — the sale of spirit in casks to other blenders, brokers, and producers — is a revenue line most consumers know nothing about, but it has long been a crucial part of Ian Macleod's business model. The company is not merely a brand house; it is deeply embedded in the infrastructure of Scotch whisky supply chains.
Ian Macleod Distillers said its bulk business was hit by "ongoing lower demand" from UK-based industry buyers for single casks, young grain and older blended malt whisky. That breadth of affected product types — single casks, young grain, older blended malt — tells you the problem is structural, not product-specific. The buyers who would normally absorb Ian Macleod's surplus production are themselves sitting on too much stock. The company added: "These effects were experienced by most competitor businesses across the sector."
Geography: North America Holds While Europe and Asia Fall
The geographic breakdown of cased goods sales reveals where optimism is still justified — and where it is not. "Cased turnover demand for group products in Europe and Asia continued to decline whilst in the United Kingdom the reduction was mild. Positively, cased turnover grew in North America," the company reported. For American drinkers, that last line matters. Even as the overall business contracted, Ian Macleod's brands — Glengoyne, Tamdhu, Smokehead, and the rest of the portfolio — found more buyers in the United States than in the prior year. That is not a coincidence; it reflects a deliberate push by the company to grow its American footprint at a time when other markets are retreating.
Gordon Dundas, Ian Macleod's advocacy director and head of brand development, made this clear earlier in 2025 when speaking about the company's strategy despite tariff headwinds. "We have whisky sitting in warehouses in Scotland. We know we have drinkers over here in America who really want to drink it," he said. That sentiment captures the company's posture with unusual clarity: the liquid exists, the demand exists, and the challenge is navigating the commercial and logistical obstacles between them.
The Broader Scotch Catastrophe: Ian Macleod Is Not Alone
As discomfiting as Ian Macleod's results are, they cannot be separated from what is happening across the entire Scotch category. Global sales of Scotch whisky declined 3% in the first half of 2025, marking the third consecutive year of decline after decades of growth, according to the alcohol data provider IWSR. The Scotch whisky category is suffering from a global downturn in sales driven by tariffs, declining alcohol consumption and cost of living pressures.
In 2025, Scotch exports fell by 0.6% in value on volumes down 4.3%, SWA figures released earlier this year showed. Those are headline numbers, but the underlying dynamics are messier. Data from the Scotch Whisky Association showed the value of Scotch whisky exports fell by 3.7% to £5.4 billion in 2024 compared with 2023. The category is contracting in real terms across both volume and value, which means producers cannot even offset volume declines with premium pricing — they are losing ground on both fronts simultaneously.
Tariffs: The Weight on the Industry's Shoulders
While Keir Starmer secured a trade deal with Donald Trump in May, whisky imports from the UK into the US are still subject to a 10% tariff, which the Scotch Whisky Association has estimated amounts to £4 million ($5.41 million) per week. The SWA also warned that US tariffs are costing the sector almost £20 million a month in lost sales, and more than 1,000 jobs. For an industry built on long-cycle investment — where decisions made in a distillery today won't reach the consumer for a decade or more — that kind of sustained external cost is particularly damaging to planning and confidence.
The Scotch industry faces a baseline 10% tariff after a deal was struck between the US and UK, and while details remain scarce, the deal provides some clarity as to what producers can expect moving forward. Dundas put the situation plainly: "You have to continue to monitor and decide how to react to the next thing that happens." That kind of reactive posture — scanning the horizon for the next policy shock — is now the operational reality for every Scotch producer with significant American exposure.
Diageo Cuts Too, and the Glut Goes Deeper
Ian Macleod is operating in company with the biggest players in the game. Diageo, the FTSE 100 drinks group behind whiskies including Johnnie Walker, Talisker and Lagavulin, has cut production at some malt distilleries to "balance capacity against current demand." Diageo has paused production at distilleries in America and Scotland, as well as malting houses; Jim Beam won't be making any whiskey at one of its main distilleries for all of 2026; Brown-Forman sold a cooperage and cut its global workforce, as well as closing one of its Scotch distilleries. The scale of the industry-wide pullback is staggering. When producers from the smallest family independents to the largest multinational conglomerates are simultaneously throttling production, it indicates a supply overhang that accumulated over years of aggressive capacity expansion during the Scotch boom of the 2010s.
Five major drinks companies — Diageo, Pernod Ricard, Campari, Brown-Forman, and Remy Cointreau — are sitting on about $22 billion worth of aged spirits, the largest amount of unsold inventory they have had in a decade. While the debate continues about what exactly might be causing this glut, analysts point to the pandemic, when people were drinking a lot more at home and producers were encouraged to increase production. Scotch, with mandatory minimum aging requirements, compounds the problem: the spirit sitting in those warehouses represents decisions made years ago, when the demand trajectory looked entirely different.
The Visitor Economy: Another Casualty
Distillery tourism has been one of the growth stories of Scottish whisky over the past decade, and Ian Macleod invested heavily in visitor infrastructure across its sites. But the accounts reveal that this revenue line also disappointed. "The required staff resource compared to visitor demand was hard to predict and in the event staff resources was more than ideal when compared to actual visitor footfall," Ian Macleod Distillers said, adding that site performance and staffing levels would be "closely monitored and continuously adjusted so that better returns are made." The candor of that admission is notable — the company over-hired for a visitor volume that did not materialize. It is a reminder that distillery tourism, while real and valuable, is not immune to the same cost-of-living and travel pressures bearing down on the rest of the premium spirits market.
Ian Macleod's History: Built for Exactly This Kind of Moment
It would be a mistake to read Ian Macleod's current challenges as evidence of fundamental weakness. Ian Macleod Distillers Ltd. is an independent, family-owned business which produces Scotch whisky and other spirits, based in Broxburn, Scotland, founded in 1933. Nine decades of independent, family-controlled operation means the company has survived the Scotch busts of the 1980s — when distilleries shuttered by the dozen during the so-called "whisky loch" era of catastrophic oversupply — as well as the post-2008 financial crisis, and the COVID disruptions of 2020.
Managing Director Leonard Russell has spoken directly about the company's capacity to absorb cyclical pain that would cripple a publicly listed competitor. "As an independent family-owned company we do not need to focus on short-term returns for shareholders but are able to focus on the longer term, in markets that have the best growth potential for our products," Russell once noted. That philosophy is precisely what allows a production cut of 30% to be described as prudent management rather than crisis response. The Russells are not answering to a quarterly earnings call; they are tending to an asset they intend to hand to the next generation.
The cyclical nature of the industry's fortunes is something Russell has acknowledged with characteristic frankness. "In the past 30 years or more there have been periods when we've been unable to sell our older whisky, and that was very stressful," he said in an earlier period of reflection. The current moment echoes those painful stretches, but the company is arguably better resourced and more diversified than at any previous downturn.
Expansion Despite Contraction: The Islay Bet
What makes Ian Macleod's current strategic position genuinely complex is that the company is simultaneously cutting production at established sites while building new ones. This April, Ian Macleod Distillers opened Laggan Bay, a new distillery based on Islay. Islay remains one of the most commercially powerful designations in single malt Scotch — a region whose peated, coastal malts command fierce loyalty and premium pricing from a global fanbase that includes an outsized proportion of American collectors and enthusiasts. Opening a new Islay distillery in the middle of a category downturn is either bold contrarianism or long-cycle thinking at its most disciplined — probably both.
Earlier this year, Glengoyne released a 24-year-old White Oak expression, and Dundas is in New York for the release of Tamdhu 43 Year Old, an ultra-rare single malt priced at US$16,000 with just 100 bottles available worldwide. Those releases tell a parallel story: even as the mass-market and bulk businesses contract, the ultra-premium and collectible end of the portfolio is being pushed forward. The logic is straightforward — margin expansion at the top tier can partially offset volume loss at the bottom.
What This Means for American Whisky Drinkers
For the American consumer who has come to appreciate Glengoyne's unpeated Highland style or has tracked down a bottle of Tamdhu's sherry-forward Speyside character, the Ian Macleod news deserves careful attention. Production cuts at the distillery level do not affect bottles already on shelves today — but they do affect what will be available in a decade. Scotch whisky ages under legal minimum requirements, and a 30% reduction in new spirit going into cask means 30% less aged product available for release years from now. If and when the market recovers, that supply constraint will be felt acutely — and the bottles coming out of Glengoyne and Rosebank in the mid-2030s may be considerably harder to find.
The tariff situation adds another layer of complication for American buyers. Despite looming tariffs, Ian Macleod intends to deliver its products to US drinkers, even as exports are down by value, distilleries are scaling back production, and a 10% tariff on goods to the US looms. The company's commitment to the North American market is genuine — Ian Macleod's advocacy director calls production pauses natural if broader demand is softening, saying the vision at the company remains long-term. "What we're seeing is that people are making more of a considered choice," Dundas said, framing the moment not as catastrophe but as a recalibration of how consumers engage with premium Scotch.
The Long View: Optimism, Carefully Earned
The Scotch industry has navigated worse. The glut of the 1980s — when Scotland's warehouses were so packed with unsold spirit that the era literally became known as the "whisky loch" — eventually resolved into one of the most sustained growth periods in the category's history. The producers who survived that contraction and kept their best liquid aging through the lean years were the ones positioned to capture the boom that followed. Ian Macleod, which used that same era to build its blending and bulk operations into something durable, understands this dynamic as well as any company in Scotland.
"Whisky is a long-term product," Dundas noted. "There's no doubt the Scottish whisky market in the long term is positive." That is not corporate spin — it is a statement grounded in the structural reality that Scotland produces a legally protected, geographically specific spirit that cannot be replicated anywhere else on earth. The brand equity accumulated by names like Glengoyne, Rosebank, and Tamdhu over decades does not evaporate in a cyclical downturn.
What Ian Macleod's filing ultimately represents is a family-owned business doing what family-owned businesses do best in a storm: protecting the balance sheet, right-sizing production to honest demand, and refusing to let short-term pressure force decisions that would damage the long-term asset. A 30% production cut stings. Half-year profits that more than halve stings. But the stills are still running, the warehouses are still filling, and the Russell family's commitment to Glengoyne, Tamdhu, and Rosebank has not wavered. In a moment when the entire Scotch industry is recalibrating, that counts for something substantial.
